You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 134 No. 5, May 1999 TABLE OF CONTENTS
  Archives
  •  Online Features
  Invited Critique
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Surgery, Other
 •Alert me on articles by topic

Invited Critique: Peritoneal Expansion by Artificially Produced Ascites During Perfusion Chemotherapy

John S. Spratt, MD
Louisville, Ky

Arch Surg. 1999;134:550.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The authors provide a modification in technique of hyperthermic peritoneal perfusion for peritoneal adenocarcinomatosis that builds on earlier studies. However, there are technical and cytokinetic limitations to their approach. From the technical standpoint, their perfusion system would not avoid streaming of flow. Like the authors, my approach would be to resect the primary cancer, omentum, and as much of the peritoneal implants as possible. Afterward, I would copiously irrigate the peritoneal cavity with 5% dextrose in water heated on last wash to 55°C and leave it in for only 3 to 5 minutes before removing. This temperature for short exposure is as thermolethal as the lower temperature used by the authors for longer periods. There is some evidence that the mucopolysaccharides forming the viscous ascites in pseudomyxoma are miscible in 5% dextrose in water. Also, 5% dextrose in water has an osmolytic effect on cells. The . . . [Full Text of this Article]


RELATED ARTICLE

Peritoneal Expansion by Artificially Produced Ascites During Perfusion Chemotherapy
Dimitris Tsiftsis, Eelco de Bree, John Romanos, Anastasios Petrou, Elias Sanidas, John Askoxylakis, Konstantinos Zervos, and Dimitris Michaloudis
Arch Surg. 1999;134(5):545-549.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.